Skip to main content
SpringerLink
Log in

Smoking Prevention and Cessation

  • Chapter
Clinical and Biological Basis of Lung Cancer Prevention

Part of the book series: Respiratory Pharmacology and Pharmacotherapy ((RPP))

Abstract

The most important etiological factor in the development of lung cancer is smoking, which accounts for approximately 80 to 85% of all lung cancer cases. Tobacco use is also a major contributor to the incidence of chronic respiratory disease (80 to 90%) and myocardial infarction (23 to 40%) [1] and has been strongly correlated with other cancers (e.g. oral, laryngeal and bladder cancers). Approximately one-third of all cancer deaths is attributed to tobacco [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. USDHHS (1990) The Health Benefits of Smoking Cessation: A Report of the Surgeon General, DHHS CDC 90-8416. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Rockville, Maryland, USA.

    Google Scholar 

  2. Peto R, Lopez AD, Boreham J, Thun M, Herth C (1994) Mortality from tobacco in developed countries 1950-2000. Oxford University Press.

    Google Scholar 

  3. WHO (1995) Guidelines for controlling and monitoring the tobacco epidemic. Pre-publication draft. WHO, Geneva.

    Google Scholar 

  4. CDC (1994) Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users. Morbidity and Mortality Weekly Report 43(41): 745–750.

    Google Scholar 

  5. IASLC Workshop (1996) Prevention and early detection of lung cancer. Clinical aspects. Proceedings, Elsinore, Denmark.

    Google Scholar 

  6. American College of Chest Physcians, American Thoracic Society, Asia Pacific Society of Respiralogy, Canadian Thoracic Society, European Respiratory Society International Union Against Tuberculosis and Lung Diseases (1995) Smoking and health: A physician’s responsibility. A statement of the joint committee on smoking and health. Eur Respir J 8: 1808–1811.

    Article  Google Scholar 

  7. USDHHS (1994) Tobacco and the Clinician Interventions for Medical and Dental Practice, NCI 94-3693. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Rockville, Maryland, USA.

    Google Scholar 

  8. Fiore MC, Bailey WC, Cohen SJ, Goldstein MG, Gritz ER, Heyman RB, et al. (1996) Smoking Cessation. Clinical Practice Guideline No 18, AHCPR 96-0692. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.

    Google Scholar 

  9. Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patch for smoking cessation. JAMA 271(24): 1940–1947.

    Article  PubMed  CAS  Google Scholar 

  10. APA (1994) Diagnostic and Statistical Manual of Mental Disorders — IV. American Psychiatric Association, Washington D.C.

    Google Scholar 

  11. Fagerström KO, Heatherton TF, Kozlowski LT (1991) Nicotine addiction and its assessment. Ear, Nose and Throat 69: 763–768.

    Google Scholar 

  12. Tønnesen P (1994) Smoking cessation programs. In: Hansen HH (ed.): Lung Cancer, Kluwer Ac. Pb., pp 75-89.

    Google Scholar 

  13. Corrigall WA (1991) Understanding brain mechanisms in nicotine reinforcement. Br J Addiction 86: 507–510.

    Article  CAS  Google Scholar 

  14. Lynch BS, Bonnie RJ (eds) (1994) Growing Up Tobacco Free-Preventing Nicotine Addiction in Children and Youths, National Academy Press, Institute of Medicine, Washington, D.C.

    Google Scholar 

  15. Silagy C, Mant D, Fowler G, Lodge M (1994) Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139–142.

    Article  PubMed  CAS  Google Scholar 

  16. Hjalmarson A (1984) Effect of nicotine chewing gum in smoking cessation: A randomized, placebo-controlled, double-blind study. JAMA 252: 2835–2838.

    Article  PubMed  CAS  Google Scholar 

  17. Hjalmarson A, Franzon M, Westin A, Wiklund O (1994) Effect of nicotine nasal spray on smoking cessation. Archs Intern Med 154: 2567–2572.

    Article  CAS  Google Scholar 

  18. Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O. The nicotine inhaler in smoking cessation: A double-blind randomized clinical evaluation. In manuscript.

    Google Scholar 

  19. Hjalmarson A. Smoking Cessation. Evaluation of supportive strategies with special reference to nicotine replacement therapy (Thesis), Goteborg University, 1996.

    Google Scholar 

  20. Benowitz NL (1988) Toxicity of nicotine: Implications with regard to nicotine replacement tharapy. In: Pomerleau OF, Pomerleau CS (eds): Nicotine replacement. A critical evaluation. Alan R. Liss, Inc, New York, pp 187–218.

    Google Scholar 

  21. McNabb ME, Ebert RV, McCusker K (1982) Plasma nicotine levels produced by chewing nicotine gum. JAMA 248: 865–868.

    Article  PubMed  CAS  Google Scholar 

  22. McNabb ME (1984) Chewing nicotine gum for 3 months: What happens to plasma nicotine levels? Can MedAssoc J 131: 589–592.

    CAS  Google Scholar 

  23. Tønnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M (1988) Two and four mg nicotine chewing gum and group counseling in smoking cessation: An open, randomized, controlled trial with a 22 month follow-up. Addict Behav 13: 17–27.

    Article  PubMed  Google Scholar 

  24. Malcolm RE, Sillett RW, Turner JAMcM, Ball KP (1980) The use of nicotine chewing gum as an aid to stopping smoking. Psychopharmacologia 70: 295–296.

    Article  CAS  Google Scholar 

  25. Fee WM, Stewart MJ (1982) A controlled trial of nicotine chewing gum in a smoking withdrawal clinic. Practitioner 5; 226: 148–151.

    CAS  Google Scholar 

  26. Fagerström KO (1982) A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med 5: 343–351.

    Article  PubMed  Google Scholar 

  27. Tønnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M (1988) Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 318:15–18.

    Article  PubMed  Google Scholar 

  28. Puska P, Bjorkqvist S, Koskela K (1979) Nicotine containing chewing gum in smoking cessation: A double-blind trial with half year follow-up. Addict Behav 4: 141–146.

    Article  PubMed  CAS  Google Scholar 

  29. Blöndal T (1989) Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med 149: 1818–1821.

    Article  PubMed  Google Scholar 

  30. Kornitzer M, Kittel F, Draimaix M. Bourdoux P (1987) A double-blind study of 2 mg versus 4 mg nicotine gum in an industrial setting. J Psychosom Res 31: 171–176.

    Article  PubMed  CAS  Google Scholar 

  31. Killen JD, Fortmann SP, Newman B, Varady A (1990) Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 58: 85–92.

    Article  PubMed  CAS  Google Scholar 

  32. Hughes JR, Gust SW, Keenan R, Fenwick JW, Skoog K, Higgins ST (1991) Long-term use of nicotine vs placebo gum. Arch Intern Med 151: 1993–1998.

    Article  PubMed  CAS  Google Scholar 

  33. Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, Nides MA, Kiley JP (1996) Safety of nicotine polacrilex gum used by 3,094 participants in the lung health study. Chest 109: 438–445.

    Article  PubMed  CAS  Google Scholar 

  34. Fagerström KO, Säwe U, Tønnesen P (1992) Therapeutic use of nicotine patches: Efficacy and safety. J Smoking-Related Dis 3: 247–261.

    Google Scholar 

  35. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. JAMA 22: 3133–3138.

    Google Scholar 

  36. Russell MAH, Stableton JA, Feyerabend C, Wiserman SM, Gustavsson G, Säwe U, Connor P. (1993) Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. Br Med J} 306: 1308–1312.

    Article  CAS  Google Scholar 

  37. Imperial Cancer Research Fund General Practice Research Group: Effectiveness of a nicotine patch in helping people to stop smoking: results of a randomised trial in general practice. (1993) Br Med J 306: 1304–1308.

    Article  Google Scholar 

  38. Tønnesen P, Nørregaard J, Mikkelsen K, Jørgensen S, Nilsson F (1993) A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 269: 1268–1271.

    Article  PubMed  Google Scholar 

  39. Schneider NG, Olmstead R, Nilsson F, Vaghaiwalla Mody F, Franzon M, Doan K (1996) Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 91(9): 1293–1306.

    Article  PubMed  CAS  Google Scholar 

  40. Sutherland G, Stapleton JA, Russell MAH, Jarvis MJ, Hajek P, Belcher M, Feyerabend C (1992) Randomised controlled trial of a nasal nicotine spray in smoking cessation. Lancet 340: 324–329.

    Article  PubMed  CAS  Google Scholar 

  41. Blondal T, Franzon M, Westin A, Olafsdottir I, Gudmundsdottir S, Gunnarsdottir R (1993) Controlled trial of nicotine nasal spray with long term follow-up. (Abstract) ARRD 147: A806.

    Google Scholar 

  42. Fagerström KO, Schneider NG, Lunnel E (1993) Effectiveness of nicotine patch and nicotine gum as individual versus combined treatment for tobacco withdrawal symptoms. Psychopharmacology 110: 251–257.

    Google Scholar 

  43. UDHHS (1988) US Department of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General, DHHS CDC 88-8406. Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Rockville, Maryland, USA.

    Google Scholar 

  44. Glourlay SG, Stead LF, Benowitz NL (1997) A meta-analysis of clonidine for smoking cessation. The Cochrane Library 1.

    Google Scholar 

  45. Gawin F, Comptom M, Byck R (1989) Buspirone reduces smoking. Arch Gen Psychiat 46: 288.

    Article  PubMed  CAS  Google Scholar 

  46. White AR, Rampes H (1997) Acupuncture in smoking cessation. The Cochrane Library 1.

    Google Scholar 

  47. Glynn TJ, Manley MW (1991) How to Help Your Patients Stop Smoking. A National Cancer Institute Manual for Physicians. NIH 92-3064. Smoking, Tobacco and Cancer Program, Division of Cancer Prevention and Control, National Cancer Institute.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department of Pulmonary Diseases, Gentofte University Hospital, Hellerup, Denmark

    Philip Tønnesen

  2. Department of Behavioral Science, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, USA

    Ellen R. Gritz & Ingrid R. Nielsen

  3. Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy

    Nigel Gray

Authors
  1. Philip Tønnesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ellen R. Gritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nigel Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ingrid R. Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital de Brabois Service de Pneumologie A, Centre Hospitalier Universitaire de Nancy, 54511, Vandoeuvre-lès-Nancy, France

    Yves Martinet

  2. The Finsen Center Department of Oncology 5074, Copenhagen University Hospital Rigshospitalet, DK-2100, Copenhagen, Denmark

    Fred R. Hirsch

  3. Unité de Recherche de Physipathologie Respiratoire, INSERM U14, C.O. No 10, 54511, Vandoeuvre-lès-Nancy, France

    Nadine Martinet

  4. Service d’Anatomie Pathologique, Centre Hospitalier Universitaire de Nancy Hôpital Central, 54035, Nancy, France

    Jean-Michel Vignaud

  5. National Cancer Institute / National Institutes of Health, Division of Clinical Sciences / Medicine Branch Cell and Cancer Biology Department, Rockville, MD, 20850-3300, USA

    James L. Mulshine

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Basel AG

About this chapter

Cite this chapter

Tønnesen, P., Gritz, E.R., Gray, N., Nielsen, I.R. (1998). Smoking Prevention and Cessation. In: Martinet, Y., Hirsch, F.R., Martinet, N., Vignaud, JM., Mulshine, J.L. (eds) Clinical and Biological Basis of Lung Cancer Prevention. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8924-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8924-7_2

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9829-4

  • Online ISBN: 978-3-0348-8924-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation